首页 > 最新文献

Progress in Neuro-Psychopharmacology & Biological Psychiatry最新文献

英文 中文
Psychedelic-related deaths in England, Wales and Northern Ireland (1997–2022) 英格兰、威尔士和北爱尔兰与迷幻药有关的死亡人数(1997-2022 年)。
IF 5.3 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-10-20 DOI: 10.1016/j.pnpbp.2024.111177
Emma I. Kopra , Jenni Penttinen , James J. Rucker , Caroline S. Copeland

Background

Psychedelic drugs are increasingly visible in society once more, but their risks and adverse effects have received less attention than perhaps they should. While fatalities associated with psychedelics appear rare, a systematic approach to characterising their aetiology is required to inform harm minimisation efforts.

Aims

This study aimed to analyse prevalence and characteristics of psychedelic-related deaths in England, Wales, and Northern Ireland, between 1997 and 2022.

Methods

We analysed coroner reports submitted to the National Programme on Substance Use Mortality where psychedelic serotonergic agonist drugs were involved in the death, and conducted a thematic framework analysis to explore potential factors associated with their occurrence.

Results

We identified 28 cases where psychedelics were implicated (75 %, N = 21) or potentially implicated (25 %, N = 7) in the death; 19 of these involving psychedelic tryptamines (LSD 39 %, N = 11; Psilocybin 21 %, N = 6; DMT 7 %, N = 2), and 9 psychedelic phenethylamines (incl. NBOMes 18 %, N = 5). Most deaths were deemed accidental by the coroner (86 %, N = 24), including both traumatic injuries and drug toxicities; most cases involved multiple implicated drugs (68 %, N = 19); and most of the deceased were under 30 years of age (82 %, N = 23). Thematic framework analysis identified nine themes in the deaths across three categories. ‘Polysubstance use’ was the most common theme (82 % of cases, N = 23/28), followed by a suboptimal ‘physical environment’ (70 % of cases where this information was available, N = 14/20).

Conclusions

The profound and often unpredictable effects of psychedelics pose a unique profile of risks and adverse reactions. Nevertheless, psychedelic-related deaths remain very rare in comparison to other recreational drugs, and frequently involve polydrug use. Implications for harm reduction and policy are discussed.
背景:迷幻药在社会上的曝光率越来越高,但其风险和不良影响却没有得到应有的关注。虽然与迷幻药有关的死亡事件似乎很少见,但仍需要一种系统的方法来描述其病因,以便为尽量减少伤害的努力提供信息。目的:本研究旨在分析1997年至2022年期间英格兰、威尔士和北爱尔兰与迷幻药有关的死亡事件的发生率和特征:我们分析了提交给 "国家药物使用死亡率计划"(National Programme on Substance Use Mortality)的验尸官报告中涉及迷幻药血清素能激动剂类药物的死亡案例,并进行了主题框架分析,以探索与这些案例发生相关的潜在因素:我们发现28例死亡与迷幻药有关(75%,N = 21)或可能与迷幻药有关(25%,N = 7);其中19例涉及迷幻色胺类药物(迷幻剂39%,N = 11;迷幻药21%,N = 6;DMT 7%,N = 2),9例涉及迷幻苯乙胺类药物(包括NBOMes 18%,N = 5)。大多数死亡被验尸官认定为意外死亡(86%,N = 24),包括外伤和药物中毒;大多数病例涉及多种涉案药物(68%,N = 19);大多数死者年龄在 30 岁以下(82%,N = 23)。主题框架分析确定了三类死亡案例中的九个主题。使用多种药物 "是最常见的主题(82%的病例,N = 23/28),其次是 "物理环境 "不理想(70%的病例有此信息,N = 14/20):结论:迷幻药的影响深远且往往难以预测,因此具有独特的风险和不良反应。尽管如此,与其他娱乐性药物相比,与迷幻药相关的死亡仍然非常罕见,而且经常涉及多种药物的使用。本文讨论了减少伤害和制定政策的意义。
{"title":"Psychedelic-related deaths in England, Wales and Northern Ireland (1997–2022)","authors":"Emma I. Kopra ,&nbsp;Jenni Penttinen ,&nbsp;James J. Rucker ,&nbsp;Caroline S. Copeland","doi":"10.1016/j.pnpbp.2024.111177","DOIUrl":"10.1016/j.pnpbp.2024.111177","url":null,"abstract":"<div><h3>Background</h3><div>Psychedelic drugs are increasingly visible in society once more, but their risks and adverse effects have received less attention than perhaps they should. While fatalities associated with psychedelics appear rare, a systematic approach to characterising their aetiology is required to inform harm minimisation efforts.</div></div><div><h3>Aims</h3><div>This study aimed to analyse prevalence and characteristics of psychedelic-related deaths in England, Wales, and Northern Ireland, between 1997 and 2022.</div></div><div><h3>Methods</h3><div>We analysed coroner reports submitted to the National Programme on Substance Use Mortality where psychedelic serotonergic agonist drugs were involved in the death, and conducted a thematic framework analysis to explore potential factors associated with their occurrence.</div></div><div><h3>Results</h3><div>We identified 28 cases where psychedelics were implicated (75 %, <em>N</em> = 21) or potentially implicated (25 %, <em>N</em> = 7) in the death; 19 of these involving psychedelic tryptamines (LSD 39 %, <em>N</em> = 11; Psilocybin 21 %, <em>N</em> = 6; DMT 7 %, <em>N</em> = 2), and 9 psychedelic phenethylamines (incl. NBOMes 18 %, <em>N</em> = 5). Most deaths were deemed accidental by the coroner (86 %, <em>N</em> = 24), including both traumatic injuries and drug toxicities; most cases involved multiple implicated drugs (68 %, <em>N</em> = 19); and most of the deceased were under 30 years of age (82 %, <em>N</em> = 23). Thematic framework analysis identified nine themes in the deaths across three categories. ‘Polysubstance use’ was the most common theme (82 % of cases, <em>N</em> = 23/28), followed by a suboptimal ‘physical environment’ (70 % of cases where this information was available, <em>N</em> = 14/20).</div></div><div><h3>Conclusions</h3><div>The profound and often unpredictable effects of psychedelics pose a unique profile of risks and adverse reactions. Nevertheless, psychedelic-related deaths remain very rare in comparison to other recreational drugs, and frequently involve polydrug use. Implications for harm reduction and policy are discussed.</div></div>","PeriodicalId":54549,"journal":{"name":"Progress in Neuro-Psychopharmacology & Biological Psychiatry","volume":"136 ","pages":"Article 111177"},"PeriodicalIF":5.3,"publicationDate":"2024-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142513102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cannabidiol exerts antipyretic effects by downmodulating inflammatory mediators in LPS-induced fever 大麻二酚在 LPS 引起的发热中通过下调炎症介质发挥解热作用。
IF 5.3 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-10-20 DOI: 10.1016/j.pnpbp.2024.111178
Emilly S.S. Andres , Patrícia Passaglia , Wanderson S. Santos , Isis P. Trajano , Renato Nery Soriano , Lucas Miranda Marques , Glauce C. Nascimento , Elaine Del-Bel , Luiz G.S. Branco
Contrasting to tetrahydrocannabinol (THC), cannabidiol (CBD) has virtually no psychoactive effects and thus presents a minor risk for abuse. Furthermore, emerging preclinical and clinical evidence indicates that CBD exerts several beneficial pharmacological effects, including anti-inflammatory and antioxidant properties. Even though fever is one of the responses associated with systemic inflammation, no previous study assessed the putative impact of CBD on lipopolysaccharide (LPS)-induced fever. The present study aimed to evaluate whether CBD exerts effects on febrile responses, by modulating the hypothalamic-pituitary-adrenal (HPA) axis, and the inflammatory reflex, in this response. CBD caused no change in euthermic mice, indicating that it does not alter euthermia. Conversely, CBD blunted all the assessed systemic inflammation parameters including fever (a hallmark of infection), plasma pro-inflammatory cytokines and prostaglandin E2 (PGE2) surges, and hypothalamic PGE2 (the proximal mediator of fever) synthesis. Moreover, CBD also reduced LPS-induced increase in plasma corticosterone levels and spleen TNF-α. These data are consistent with the notion that CBD has antipyretic effects, reducing peripheral febrigenic signaling (plasma pro-inflammatory cytokines levels), and eventually down-modulating hypothalamic PGE2 production, possibly in a corticosterone- and inflammatory reflex-dependent manner.
与四氢大麻酚(THC)不同,大麻二酚(CBD)几乎没有精神活性作用,因此滥用风险较小。此外,新出现的临床前和临床证据表明,大麻二酚具有多种有益的药理作用,包括抗炎和抗氧化特性。尽管发热是与全身性炎症相关的反应之一,但以前没有研究评估过 CBD 对脂多糖(LPS)诱导的发热的潜在影响。本研究旨在评估 CBD 是否通过调节下丘脑-垂体-肾上腺(HPA)轴和炎症反射来影响发热反应。CBD 对热病小鼠没有影响,表明它不会改变热病。相反,CBD 可减弱所有评估的全身炎症参数,包括发热(感染的标志)、血浆促炎细胞因子和前列腺素 E2(PGE2)激增以及下丘脑 PGE2(发热的近端介质)合成。此外,CBD 还能减少 LPS 引起的血浆皮质酮水平和脾脏 TNF-α 的增加。这些数据与 CBD 具有解热作用、减少外周发热信号传导(血浆促炎细胞因子水平)并最终下调下丘脑 PGE2 生成的观点一致,这可能是一种依赖于皮质酮和炎症反射的方式。
{"title":"Cannabidiol exerts antipyretic effects by downmodulating inflammatory mediators in LPS-induced fever","authors":"Emilly S.S. Andres ,&nbsp;Patrícia Passaglia ,&nbsp;Wanderson S. Santos ,&nbsp;Isis P. Trajano ,&nbsp;Renato Nery Soriano ,&nbsp;Lucas Miranda Marques ,&nbsp;Glauce C. Nascimento ,&nbsp;Elaine Del-Bel ,&nbsp;Luiz G.S. Branco","doi":"10.1016/j.pnpbp.2024.111178","DOIUrl":"10.1016/j.pnpbp.2024.111178","url":null,"abstract":"<div><div>Contrasting to tetrahydrocannabinol (THC), cannabidiol (CBD) has virtually no psychoactive effects and thus presents a minor risk for abuse. Furthermore, emerging preclinical and clinical evidence indicates that CBD exerts several beneficial pharmacological effects, including anti-inflammatory and antioxidant properties. Even though fever is one of the responses associated with systemic inflammation, no previous study assessed the putative impact of CBD on lipopolysaccharide (LPS)-induced fever. The present study aimed to evaluate whether CBD exerts effects on febrile responses, by modulating the hypothalamic-pituitary-adrenal (HPA) axis, and the inflammatory reflex, in this response. CBD caused no change in euthermic mice, indicating that it does not alter euthermia. Conversely, CBD blunted all the assessed systemic inflammation parameters including fever (a hallmark of infection), plasma pro-inflammatory cytokines and prostaglandin E<sub>2</sub> (PGE<sub>2</sub>) surges, and hypothalamic PGE<sub>2</sub> (the proximal mediator of fever) synthesis. Moreover, CBD also reduced LPS-induced increase in plasma corticosterone levels and spleen TNF-α. These data are consistent with the notion that CBD has antipyretic effects, reducing peripheral febrigenic signaling (plasma pro-inflammatory cytokines levels), and eventually down-modulating hypothalamic PGE<sub>2</sub> production, possibly in a corticosterone- and inflammatory reflex-dependent manner.</div></div>","PeriodicalId":54549,"journal":{"name":"Progress in Neuro-Psychopharmacology & Biological Psychiatry","volume":"136 ","pages":"Article 111178"},"PeriodicalIF":5.3,"publicationDate":"2024-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142513100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
NRN1 genetic variability and methylation changes as biomarkers for cognitive remediation therapy response in schizophrenia 将 NRN1 基因变异和甲基化变化作为精神分裂症患者认知矫正治疗反应的生物标志物。
IF 5.3 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-10-18 DOI: 10.1016/j.pnpbp.2024.111175
Carmen Almodóvar-Payá , Irene París-Gómez , Mariona Latorre-Guardia , Maria Guardiola-Ripoll , Rosa Catalán , Bárbara Arias , Rafael Penadés , Mar Fatjó-Vilas
Cognitive remediation therapy (CRT) demonstrates potential in enhancing cognitive function in schizophrenia (SZ), though the identification of molecular biomarkers remains challenging. The Neuritin-1 gene (NRN1) emerges as a promising candidate gene due to its association with SZ, cognitive performance and response to neurotherapeutic treatments. We aimed to investigate whether NRN1 genetic variability and methylation changes following CRT are related to cognitive improvements.
Twenty-five SZ patients were randomly assigned to CRT or treatment-as-usual (TAU) groups, with cognitive function and NRN1 methylation assessed pre- and post-intervention using the MATRICS Consensus Cognitive Battery and EpiTYPER. Besides, eleven NRN1 polymorphisms were genotyped. Methylation changes (Δm = post - pre) were analyzed via sparse Partial Least Square Discriminant Analysis (sPLS-DA) to identify latent components (LCs) distinguishing CRT from TAU. To further explore methylation patterns of these LCs, CpG units were grouped into two subsets, yielding Δm means for those with increased and decreased methylation. Cognitive changes (Δcog = post - pre) were used to identify CRT improvers (CRT-I, Δcog ≥ 1), and the association between methylation changes and cognitive improvements post-therapy was also tested.
We identified two LCs that differentiated CRT from TAU with a classification error rate of 0.28. The main component, LC1, included 25 CpG units. The subsets of CpG units with increased and decreased post-therapy methylation differed significantly between the two treatment arms, suggesting that differences were not merely data-driven but reflected meaningful biological variation. Additionally, CpG units linked to therapy were also associated with cognitive improvement, with LC1 and the subset of CpG units showing increased methylation post-therapy distinguishing CRT-I from the rest of the patients across multiple cognitive domains. Furthermore, the effect of LC1 on speed processing improvement after CRT was enhanced by considering the NRN1-rs9405890 polymorphism. Notably, these CpG units, particularly those with increased methylation after CRT, overlapped with key gene regulatory elements.
Our model, integrating genetics and epigenetics, boosts the understanding of CRT response variability and highlights this multi-level approach as a promising strategy for identifying potential NRN1-related biomarkers of CRT effects, though further studies with larger samples are needed.
认知矫正治疗(CRT)在增强精神分裂症(SZ)患者的认知功能方面具有潜力,但分子生物标志物的鉴定仍具有挑战性。神经营养素-1基因(NRN1)与精神分裂症、认知能力和对神经疗法的反应有关,因此成为一个有希望的候选基因。我们旨在研究 CRT 后 NRN1 基因变异和甲基化变化是否与认知能力改善有关。25名SZ患者被随机分配到CRT组或治疗照常组(TAU),使用MATRICS共识认知测验和EpiTYPER评估干预前后的认知功能和NRN1甲基化。此外,还对 11 种 NRN1 多态性进行了基因分型。甲基化变化(Δm = 后-前)通过稀疏偏最小平方判别分析(sPLS-DA)进行分析,以确定区分CRT和TAU的潜在成分(LC)。为进一步探索这些潜在成分的甲基化模式,将 CpG 单元分为两个子集,得出甲基化增加和减少的 CpG 单元的 Δm 平均值。认知变化(Δcog = 治疗后 - 治疗前)被用来识别 CRT 改善者(CRTI,Δcog ≥1),甲基化变化与治疗后认知改善之间的关联也被测试出来。我们确定了两个 LCs,它们能将 CRT 与 TAU 区分开来,分类错误率为 0.28。主要成分 LC1 包括 25 个 CpG 单元。治疗后甲基化增加和减少的 CpG 单元子集在两个治疗组之间存在显著差异,这表明差异不仅仅是数据驱动的,而是反映了有意义的生物学变异。此外,与治疗相关的 CpG 单元也与认知改善有关,LC1 和治疗后甲基化增加的 CpG 单元子集在多个认知领域将 CRT-I 与其他患者区分开来。此外,考虑到 NRN1-rs9405890 多态性,LC1 对 CRT 后速度处理改善的影响得到了加强。值得注意的是,这些CpG单元,尤其是那些在CRT后甲基化增加的单元,与关键的基因调控元件重叠。我们的模型整合了遗传学和表观遗传学,加深了人们对 CRT 反应变异性的理解,并强调了这种多层次方法是一种很有前景的策略,可用于鉴定 CRT 效果的潜在 NRN1 相关生物标记物,不过还需要对更大样本进行进一步研究。
{"title":"NRN1 genetic variability and methylation changes as biomarkers for cognitive remediation therapy response in schizophrenia","authors":"Carmen Almodóvar-Payá ,&nbsp;Irene París-Gómez ,&nbsp;Mariona Latorre-Guardia ,&nbsp;Maria Guardiola-Ripoll ,&nbsp;Rosa Catalán ,&nbsp;Bárbara Arias ,&nbsp;Rafael Penadés ,&nbsp;Mar Fatjó-Vilas","doi":"10.1016/j.pnpbp.2024.111175","DOIUrl":"10.1016/j.pnpbp.2024.111175","url":null,"abstract":"<div><div>Cognitive remediation therapy (CRT) demonstrates potential in enhancing cognitive function in schizophrenia (SZ), though the identification of molecular biomarkers remains challenging. The Neuritin-1 gene (<em>NRN1</em>) emerges as a promising candidate gene due to its association with SZ, cognitive performance and response to neurotherapeutic treatments. We aimed to investigate whether <em>NRN1</em> genetic variability and methylation changes following CRT are related to cognitive improvements.</div><div>Twenty-five SZ patients were randomly assigned to CRT or treatment-as-usual (TAU) groups, with cognitive function and <em>NRN1</em> methylation assessed pre- and post-intervention using the MATRICS Consensus Cognitive Battery and EpiTYPER. Besides, eleven <em>NRN1</em> polymorphisms were genotyped. Methylation changes (Δm = post - pre) were analyzed via sparse Partial Least Square Discriminant Analysis (sPLS-DA) to identify latent components (LCs) distinguishing CRT from TAU. To further explore methylation patterns of these LCs, CpG units were grouped into two subsets, yielding Δm means for those with increased and decreased methylation. Cognitive changes (Δcog = post - pre) were used to identify CRT improvers (CRT-I, Δcog ≥ 1), and the association between methylation changes and cognitive improvements post-therapy was also tested.</div><div>We identified two LCs that differentiated CRT from TAU with a classification error rate of 0.28. The main component, LC1, included 25 CpG units. The subsets of CpG units with increased and decreased post-therapy methylation differed significantly between the two treatment arms, suggesting that differences were not merely data-driven but reflected meaningful biological variation. Additionally, CpG units linked to therapy were also associated with cognitive improvement, with LC1 and the subset of CpG units showing increased methylation post-therapy distinguishing CRT-I from the rest of the patients across multiple cognitive domains. Furthermore, the effect of LC1 on speed processing improvement after CRT was enhanced by considering the <em>NRN1</em>-rs9405890 polymorphism. Notably, these CpG units, particularly those with increased methylation after CRT, overlapped with key gene regulatory elements.</div><div>Our model, integrating genetics and epigenetics, boosts the understanding of CRT response variability and highlights this multi-level approach as a promising strategy for identifying potential <em>NRN1</em>-related biomarkers of CRT effects, though further studies with larger samples are needed.</div></div>","PeriodicalId":54549,"journal":{"name":"Progress in Neuro-Psychopharmacology & Biological Psychiatry","volume":"136 ","pages":"Article 111175"},"PeriodicalIF":5.3,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142481079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the genetic landscape of the brain-heart axis: A comprehensive analysis of pleiotropic effects between heart disease and psychiatric disorders 探索脑-心轴的遗传景观:全面分析心脏病和精神疾病之间的多效应。
IF 5.3 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-10-17 DOI: 10.1016/j.pnpbp.2024.111172
Qifeng Song , Cheng Zhang , Wei Wang , Cihan Wang , Chenlong Yi

Background

The genetic links between heart disease and psychiatric disorders are complex and not well understood. This study uses genome-wide association studies (GWAS) and advanced multilevel analyses to explore these connections.

Methods

We analyzed GWAS data from seven psychiatric disorders and five types of heart disease. Genetic correlations and overlaps were examined using linkage disequilibrium score regression (LDSC), high-definition likelihood (HDL), and Genetic analysis incorporating Pleiotropy and Annotation (GPA). Pleiotropic single-nucleotide variations (SNVs) were identified with pleiotropic analysis under the composite null hypothesis (PLACO) and annotated via Functional mapping and annotation of genetic associations (FUMA). Potential pleiotropic genes were identified using Multi-marker Analysis of GenoMic Annotation (MAGMA) and Summary data-based Mendelian Randomization (SMR).

Results

Among 35 trait pairs, 32 showed significant genetic correlations or overlaps. PLACO identified 15,077 SNVs, with 287 recognized as pleiotropic loci and 20 colocalization sites. MAGMA and SMR revealed 75 potential pleiotropic genes involved in diverse pathways, including cancer, neurodevelopment, and cellular organization. Mouse Genome Informatics (MGI) queries provided evidence linking multiple genes to heart or psychiatric disorders.

Conclusions

This analysis reveals loci and genes with pleiotropic effects between heart disease and psychiatric disorders, highlighting shared biological pathways. These findings illuminate the genetic mechanisms underlying the brain-heart axis and suggest shared biological foundations for these conditions, offering potential targets for future prevention and treatment strategies.
背景:心脏病和精神疾病之间的遗传联系非常复杂,而且尚未得到很好的理解。本研究利用全基因组关联研究(GWAS)和先进的多层次分析来探讨这些联系:我们分析了七种精神疾病和五种心脏病的全基因组关联研究数据。方法:我们分析了七种精神疾病和五种心脏病的 GWAS 数据,并使用连锁不平衡评分回归(LDSC)、高分辨率似然法(HDL)和包含多向性和注释的遗传分析(GPA)研究了遗传相关性和重叠性。通过复合零假设下的多义性分析(PLACO)确定了多义性单核苷酸变异(SNV),并通过遗传关联的功能图谱和注释(FUMA)进行了注释。潜在的多向性基因是通过基因微注释多标记分析(MAGMA)和基于摘要数据的孟德尔随机化(SMR)确定的。采用孟德尔随机法评估因果关系:在 35 个性状对中,32 个性状显示出显著的遗传相关性或重叠性。PLACO 发现了 15,077 个 SNV,其中 287 个被认为是多效基因位点,20 个是共定位点。MAGMA 和 SMR 揭示了 75 个潜在的多效基因,这些基因涉及不同的途径,包括癌症、神经发育和细胞组织。小鼠基因组信息学(MGI)查询提供了多个基因与心脏或精神疾病相关的证据:这项分析揭示了心脏病和精神疾病之间具有多效应的基因位点和基因,突出了共同的生物通路。这些发现阐明了脑-心轴的遗传机制,并提出了这些疾病的共同生物学基础,为未来的预防和治疗策略提供了潜在的目标。
{"title":"Exploring the genetic landscape of the brain-heart axis: A comprehensive analysis of pleiotropic effects between heart disease and psychiatric disorders","authors":"Qifeng Song ,&nbsp;Cheng Zhang ,&nbsp;Wei Wang ,&nbsp;Cihan Wang ,&nbsp;Chenlong Yi","doi":"10.1016/j.pnpbp.2024.111172","DOIUrl":"10.1016/j.pnpbp.2024.111172","url":null,"abstract":"<div><h3>Background</h3><div>The genetic links between heart disease and psychiatric disorders are complex and not well understood. This study uses genome-wide association studies (GWAS) and advanced multilevel analyses to explore these connections.</div></div><div><h3>Methods</h3><div>We analyzed GWAS data from seven psychiatric disorders and five types of heart disease. Genetic correlations and overlaps were examined using linkage disequilibrium score regression (LDSC), high-definition likelihood (HDL), and Genetic analysis incorporating Pleiotropy and Annotation (GPA). Pleiotropic single-nucleotide variations (SNVs) were identified with pleiotropic analysis under the composite null hypothesis (PLACO) and annotated via Functional mapping and annotation of genetic associations (FUMA). Potential pleiotropic genes were identified using Multi-marker Analysis of GenoMic Annotation (MAGMA) and Summary data-based Mendelian Randomization (SMR).</div></div><div><h3>Results</h3><div>Among 35 trait pairs, 32 showed significant genetic correlations or overlaps. PLACO identified 15,077 SNVs, with 287 recognized as pleiotropic loci and 20 colocalization sites. MAGMA and SMR revealed 75 potential pleiotropic genes involved in diverse pathways, including cancer, neurodevelopment, and cellular organization. Mouse Genome Informatics (MGI) queries provided evidence linking multiple genes to heart or psychiatric disorders.</div></div><div><h3>Conclusions</h3><div>This analysis reveals loci and genes with pleiotropic effects between heart disease and psychiatric disorders, highlighting shared biological pathways. These findings illuminate the genetic mechanisms underlying the brain-heart axis and suggest shared biological foundations for these conditions, offering potential targets for future prevention and treatment strategies.</div></div>","PeriodicalId":54549,"journal":{"name":"Progress in Neuro-Psychopharmacology & Biological Psychiatry","volume":"136 ","pages":"Article 111172"},"PeriodicalIF":5.3,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142481078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Levodopa therapy affects brain functional network dynamics in Parkinson's disease 左旋多巴疗法影响帕金森病患者的大脑功能网络动态。
IF 5.3 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-10-12 DOI: 10.1016/j.pnpbp.2024.111169
Xiaojin Liu , Yuze Zhang , Yihe Weng , Miao Zhong , Lijuan Wang , Zhenni Gao , Huiqing Hu , Yuhu Zhang , Biao Huang , Ruiwang Huang
Levodopa (L-dopa) therapy is the most effective pharmacological treatment for motor symptoms of Parkinson's disease (PD). However, its effect on brain functional network dynamics is still unclear. Here, we recruited 26 PD patients and 24 healthy controls, and acquired their resting-state functional MRI data before (PD-OFF) and after (PD-ON) receiving 400 mg L-dopa. Using the independent component analysis and the sliding-window approach, we estimated the dynamic functional connectivity (dFC) and examined the effect of L-dopa on the temporal properties of dFC states, the variability of dFC and functional network topological organization. We found that PD-ON showed decreased mean dwell time in sparsely connected State 2 than PD-OFF, the transformation of the dFC state is more frequent and the variability of dFC was decreased within the auditory network and sensorimotor network in PD-ON. Our findings provide new insights to understand the dynamic neural activity induced by L-dopa therapy in PD patients.
左旋多巴(L-多巴)疗法是治疗帕金森病(PD)运动症状最有效的药物疗法。然而,它对大脑功能网络动态的影响仍不清楚。在此,我们招募了26名帕金森病患者和24名健康对照者,分别在接受400毫克左旋多巴治疗前(PD-OFF)和治疗后(PD-ON)采集了他们的静息态功能磁共振成像数据。我们使用独立成分分析和滑动窗口法估算了动态功能连通性(dFC),并研究了左旋多巴对dFC状态的时间特性、dFC的变异性和功能网络拓扑组织的影响。我们发现,与PD-OFF相比,PD-ON在稀疏连接状态2中的平均停留时间减少了,dFC状态的转换更加频繁,并且在PD-ON的听觉网络和感觉运动网络中dFC的变异性降低了。我们的研究结果为理解左旋多巴治疗诱导的帕金森病患者动态神经活动提供了新的见解。
{"title":"Levodopa therapy affects brain functional network dynamics in Parkinson's disease","authors":"Xiaojin Liu ,&nbsp;Yuze Zhang ,&nbsp;Yihe Weng ,&nbsp;Miao Zhong ,&nbsp;Lijuan Wang ,&nbsp;Zhenni Gao ,&nbsp;Huiqing Hu ,&nbsp;Yuhu Zhang ,&nbsp;Biao Huang ,&nbsp;Ruiwang Huang","doi":"10.1016/j.pnpbp.2024.111169","DOIUrl":"10.1016/j.pnpbp.2024.111169","url":null,"abstract":"<div><div>Levodopa (L-dopa) therapy is the most effective pharmacological treatment for motor symptoms of Parkinson's disease (PD). However, its effect on brain functional network dynamics is still unclear. Here, we recruited 26 PD patients and 24 healthy controls, and acquired their resting-state functional MRI data before (PD-OFF) and after (PD-ON) receiving 400 mg L-dopa. Using the independent component analysis and the sliding-window approach, we estimated the dynamic functional connectivity (dFC) and examined the effect of L-dopa on the temporal properties of dFC states, the variability of dFC and functional network topological organization. We found that PD-ON showed decreased mean dwell time in sparsely connected State 2 than PD-OFF, the transformation of the dFC state is more frequent and the variability of dFC was decreased within the auditory network and sensorimotor network in PD-ON. Our findings provide new insights to understand the dynamic neural activity induced by L-dopa therapy in PD patients.</div></div>","PeriodicalId":54549,"journal":{"name":"Progress in Neuro-Psychopharmacology & Biological Psychiatry","volume":"136 ","pages":"Article 111169"},"PeriodicalIF":5.3,"publicationDate":"2024-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142481080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Disentangling negative reinforcement, working memory, and deductive reasoning deficits in elevated BMI 解除负强化、工作记忆和演绎推理缺陷对体重指数升高的影响
IF 5.3 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-10-12 DOI: 10.1016/j.pnpbp.2024.111173
Gibson Weydmann , Igor Palmieri , Reinaldo A.G. Simões , Samara Buchmann , Eduardo Schmidt , Paulina Alves , Lisiane Bizarro
Neuropsychological data suggest that being overweight or obese is associated with a tendency to perseverate behavior despite negative feedback. This deficit might be observed due to other cognitive factors, such as working memory (WM) deficits or decreased ability to deduce model-based strategies when learning by trial-and-error. In the present study, a group of subjects with overweight or obesity (Ow/Ob, n = 30) was compared to normal-weight individuals (n = 42) in a modified Reinforcement Learning (RL) task. The task was designed to control WM effects on learning by manipulating cognitive load and to foster model-based learning via deductive reasoning. Computational modelling and analysis were conducted to isolate parameters related to RL mechanisms, WM use, and model-based learning (deduction parameter). Results showed that subjects with Ow/Ob had a higher number of perseverative errors and used a weaker deduction mechanism in their performance than control individuals, indicating impairments in negative reinforcement and model-based learning, whereas WM impairments were not responsible for deficits in RL. The present data suggests that obesity is associated with impairments in negative reinforcement and model-based learning.
神经心理学数据表明,超重或肥胖与不顾负面反馈坚持行为的倾向有关。这种缺陷可能是由于其他认知因素造成的,如工作记忆(WM)缺陷或在试错学习时推断基于模型的策略的能力下降。在本研究中,一组超重或肥胖的受试者(Ow/Ob,n = 30)与体重正常的受试者(n = 42)在一项改进的强化学习(RL)任务中进行了比较。该任务旨在通过控制认知负荷来控制WM对学习的影响,并通过演绎推理来促进基于模型的学习。研究人员进行了计算建模和分析,以分离出与 RL 机制、WM 使用和基于模型的学习(演绎参数)相关的参数。结果表明,与对照组相比,患有Ow/Ob的受试者有更多的持久性错误,并且在其表现中使用的演绎机制更弱,这表明他们在负强化和基于模型的学习方面存在障碍,而WM障碍并不是导致RL缺陷的原因。本研究数据表明,肥胖与负强化和基于模型的学习障碍有关。
{"title":"Disentangling negative reinforcement, working memory, and deductive reasoning deficits in elevated BMI","authors":"Gibson Weydmann ,&nbsp;Igor Palmieri ,&nbsp;Reinaldo A.G. Simões ,&nbsp;Samara Buchmann ,&nbsp;Eduardo Schmidt ,&nbsp;Paulina Alves ,&nbsp;Lisiane Bizarro","doi":"10.1016/j.pnpbp.2024.111173","DOIUrl":"10.1016/j.pnpbp.2024.111173","url":null,"abstract":"<div><div>Neuropsychological data suggest that being overweight or obese is associated with a tendency to perseverate behavior despite negative feedback. This deficit might be observed due to other cognitive factors, such as working memory (WM) deficits or decreased ability to deduce model-based strategies when learning by trial-and-error. In the present study, a group of subjects with overweight or obesity (Ow/Ob, <em>n</em> = 30) was compared to normal-weight individuals (<em>n</em> = 42) in a modified Reinforcement Learning (RL) task. The task was designed to control WM effects on learning by manipulating cognitive load and to foster model-based learning via deductive reasoning. Computational modelling and analysis were conducted to isolate parameters related to RL mechanisms, WM use, and model-based learning (deduction parameter). Results showed that subjects with Ow/Ob had a higher number of perseverative errors and used a weaker deduction mechanism in their performance than control individuals, indicating impairments in negative reinforcement and model-based learning, whereas WM impairments were not responsible for deficits in RL. The present data suggests that obesity is associated with impairments in negative reinforcement and model-based learning.</div></div>","PeriodicalId":54549,"journal":{"name":"Progress in Neuro-Psychopharmacology & Biological Psychiatry","volume":"136 ","pages":"Article 111173"},"PeriodicalIF":5.3,"publicationDate":"2024-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142441719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Understanding sex and populational differences in spatio-temporal exploration patterns and homebase dynamics of zebrafish following repeated ethanol exposure 了解斑马鱼反复接触乙醇后的时空探索模式和家园动态的性别和种群差异
IF 5.3 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-10-11 DOI: 10.1016/j.pnpbp.2024.111171
Cássio M. Resmim , João V. Borba , Falco L. Gonçalves , Laura W. Santos , Julia Canzian , Barbara D. Fontana , Maribel A. Rubin , Denis B. Rosemberg
Ethanol (EtOH) is one of the most widely consumed substance, affecting neurobehavioral functions depending on multiple environmental and biological factors. Although EtOH modulates zebrafish (Danio rerio) anxiety-like behaviors in novelty-based paradigms, the potential role of biological sex and populational variability in the exploratory dynamics in the open field test (OFT) is unknown. Here, we explored whether a repeated EtOH exposure protocol modulates the spatio-temporal exploration and homebase-related parameters in a population- and sex-dependent manner. Male and female fish from the short-fin (SF) and leopard (LEO) phenotypes were exposed to EtOH for 7 days (1 % v/v, 20 min per day). On the 8th day, the OFT was performed to assess locomotor and exploratory behaviors. We verified significant populational differences in the baseline spatio-temporal exploration patterns, supporting a pronounced anxiety in LEO with a higher homebase index compared to SF. We also found sex-dependent differences in EtOH sensitivity, where SF was more sensitive to EtOH, especially in females, which showed marked alterations in thigmotaxis and homebase occupancy. Conversely, only LEO female subjects showed increased center occupancy following EtOH. Principal component analysis (PCA) showed the main components that explained data variability, which were sex- and population-dependent. Overall, our novel findings support the utility of zebrafish-based models to assess how EtOH influences the exploratory profile in the OFT, as well as to elucidate potential differences of sex and population in the neurobehavioral responses of alcohol exposure in a translational perspective.
乙醇(EtOH)是消费最广泛的物质之一,它对神经行为功能的影响取决于多种环境和生物因素。虽然乙醇能调节斑马鱼(Danio rerio)在基于新奇事物的范式中的焦虑样行为,但生物性别和种群变异在开放场试验(OFT)的探索动态中的潜在作用尚不清楚。在此,我们探讨了重复EtOH暴露方案是否会以种群和性别依赖的方式调节探索的时空和归巢相关参数。短鳍(SF)和豹纹(LEO)表型的雌雄鱼在EtOH中暴露7天(1 % v/v,每天20分钟)。第8天,进行OFT以评估运动和探索行为。我们验证了基线时空探索模式的显著种群差异,与 SF 相比,LEO 具有更高的家园指数,这支持了 LEO 明显的焦虑。我们还发现了EtOH敏感性的性别差异,SF对EtOH更敏感,尤其是雌性SF,在移行和母巢占据方面表现出明显的变化。相反,只有LEO女性受试者在EtOH作用下中心占据率增加。主成分分析(PCA)显示了解释数据变化的主要成分,这些成分与性别和人群有关。总之,我们的新发现支持以斑马鱼为基础的模型评估EtOH如何影响OFT的探索特征,以及从转化的角度阐明酒精暴露对神经行为反应的潜在性别和人群差异。
{"title":"Understanding sex and populational differences in spatio-temporal exploration patterns and homebase dynamics of zebrafish following repeated ethanol exposure","authors":"Cássio M. Resmim ,&nbsp;João V. Borba ,&nbsp;Falco L. Gonçalves ,&nbsp;Laura W. Santos ,&nbsp;Julia Canzian ,&nbsp;Barbara D. Fontana ,&nbsp;Maribel A. Rubin ,&nbsp;Denis B. Rosemberg","doi":"10.1016/j.pnpbp.2024.111171","DOIUrl":"10.1016/j.pnpbp.2024.111171","url":null,"abstract":"<div><div>Ethanol (EtOH) is one of the most widely consumed substance, affecting neurobehavioral functions depending on multiple environmental and biological factors. Although EtOH modulates zebrafish (<em>Danio rerio</em>) anxiety-like behaviors in novelty-based paradigms, the potential role of biological sex and populational variability in the exploratory dynamics in the open field test (OFT) is unknown. Here, we explored whether a repeated EtOH exposure protocol modulates the spatio-temporal exploration and homebase-related parameters in a population- and sex-dependent manner. Male and female fish from the short-fin (SF) and leopard (LEO) phenotypes were exposed to EtOH for 7 days (1 % <em>v</em>/v, 20 min per day). On the 8th day, the OFT was performed to assess locomotor and exploratory behaviors. We verified significant populational differences in the baseline spatio-temporal exploration patterns, supporting a pronounced anxiety in LEO with a higher homebase index compared to SF. We also found sex-dependent differences in EtOH sensitivity, where SF was more sensitive to EtOH, especially in females, which showed marked alterations in thigmotaxis and homebase occupancy. Conversely, only LEO female subjects showed increased center occupancy following EtOH. Principal component analysis (PCA) showed the main components that explained data variability, which were sex- and population-dependent. Overall, our novel findings support the utility of zebrafish-based models to assess how EtOH influences the exploratory profile in the OFT, as well as to elucidate potential differences of sex and population in the neurobehavioral responses of alcohol exposure in a translational perspective.</div></div>","PeriodicalId":54549,"journal":{"name":"Progress in Neuro-Psychopharmacology & Biological Psychiatry","volume":"136 ","pages":"Article 111171"},"PeriodicalIF":5.3,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142445843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Associations between intestinal fatty-acid binding protein and clinical and metabolic characteristics of depression 肠道脂肪酸结合蛋白与抑郁症的临床和代谢特征之间的关系。
IF 5.3 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-10-10 DOI: 10.1016/j.pnpbp.2024.111170
Oliwia Gawlik-Kotelnicka , Karolina Czarnecka-Chrebelska , Aleksandra Margulska , Ewa Pikus , Jakub Wasiak , Anna Skowrońska , Ewa Brzeziańska-Lasota , Dominik Strzelecki
Introduction: The topic of increased intestinal permeability is associated with disruption of the intestinal barrier, leading to the “leaky gut” syndrome. Depressive disorders often coexist with abdominal obesity, metabolic syndrome, or its components and complications. Intestinal permeability has been proven to relate to all of the above. Methods: In this cross-sectional study, we aimed to assess the “leaky gut” blood biomarker - intestinal fatty acid-binding protein (I-FABP) - in 114 adult patients diagnosed with depressive disorders depending on abdominal obesity comorbidity, depression, anxiety, and stress level, or antidepressant use. The corrected p-value was set at 0.02. We analyzed patients' mental state, diet, anthropometric parameters, metabolic laboratory markers and I-FABP. Results: There was no difference in circulating I-FABP levels between obese and non-obese patients with depressive disorders (p = 0.648). Similarly, I-FABP levels were not different in patients with different emotional symptoms severity (p = 0.829 for self-assessed depression, p = 0.164 for anxiety, and p = 0.543 for stress). But, I-FABP levels differed significantly between patients treated and not treated with antidepressants (p = 0.011). In general linear model analysis treatment with antidepressants, anxiety severity level, their interaction, along with smoking status, drinks intake, and using dietary supplements were shown to significantly explain I-FABP variance (p < 0.001, R2adj = 0.261). Conclusions: Comorbid obesity did not increase intestinal permeability circulating marker, I-FABP, in the population of patients with depressive disorders. Treatment with antidepressants may be connected to higher I-FABP levels. Using dietary supplements, drinks intake, smoking status, or anxiety level may serve as explanatory factors.
导言:肠道渗透性增加与肠道屏障破坏有关,导致 "肠漏 "综合征。抑郁症往往与腹部肥胖、代谢综合征或其组成部分和并发症同时存在。肠道渗透性已被证明与上述所有因素有关:在这项横断面研究中,我们根据腹型肥胖合并症、抑郁、焦虑和压力水平或抗抑郁药的使用情况,评估了 114 名被诊断为抑郁症的成年患者的 "肠漏 "血液生物标志物--肠脂肪酸结合蛋白(I-FABP)。校正后的 P 值定为 0.02。我们分析了患者的精神状态、饮食、人体测量参数、代谢实验室指标和 I-FABP:结果:肥胖和非肥胖抑郁症患者的循环 I-FABP 水平没有差异(p = 0.648)。同样,不同情绪症状严重程度的患者的 I-FABP 水平也没有差异(自评抑郁 p = 0.829,焦虑 p = 0.164,压力 p = 0.543)。但是,I-FABP 水平在接受抗抑郁药物治疗和未接受抗抑郁药物治疗的患者之间存在显著差异(p = 0.011)。在一般线性模型分析中,抗抑郁药物治疗、焦虑严重程度、它们之间的交互作用,以及吸烟状况、饮料摄入量和使用膳食补充剂都能显著解释 I-FABP 变异(p 2adj = 0.261):结论:在抑郁症患者中,合并肥胖并不会增加肠道渗透性循环标志物 I-FABP。使用抗抑郁药治疗可能与 I-FABP 水平升高有关。使用膳食补充剂、饮料摄入量、吸烟状况或焦虑程度可能是解释因素。
{"title":"Associations between intestinal fatty-acid binding protein and clinical and metabolic characteristics of depression","authors":"Oliwia Gawlik-Kotelnicka ,&nbsp;Karolina Czarnecka-Chrebelska ,&nbsp;Aleksandra Margulska ,&nbsp;Ewa Pikus ,&nbsp;Jakub Wasiak ,&nbsp;Anna Skowrońska ,&nbsp;Ewa Brzeziańska-Lasota ,&nbsp;Dominik Strzelecki","doi":"10.1016/j.pnpbp.2024.111170","DOIUrl":"10.1016/j.pnpbp.2024.111170","url":null,"abstract":"<div><div>Introduction: The topic of increased intestinal permeability is associated with disruption of the intestinal barrier, leading to the “leaky gut” syndrome. Depressive disorders often coexist with abdominal obesity, metabolic syndrome, or its components and complications. Intestinal permeability has been proven to relate to all of the above. Methods: In this cross-sectional study, we aimed to assess the “leaky gut” blood biomarker - intestinal fatty acid-binding protein (I-FABP) - in 114 adult patients diagnosed with depressive disorders depending on abdominal obesity comorbidity, depression, anxiety, and stress level, or antidepressant use. The corrected <em>p</em>-value was set at 0.02. We analyzed patients' mental state, diet, anthropometric parameters, metabolic laboratory markers and I-FABP. Results: There was no difference in circulating I-FABP levels between obese and non-obese patients with depressive disorders (<em>p</em> = 0.648). Similarly, I-FABP levels were not different in patients with different emotional symptoms severity (<em>p</em> = 0.829 for self-assessed depression, <em>p</em> = 0.164 for anxiety, and <em>p</em> = 0.543 for stress). But, I-FABP levels differed significantly between patients treated and not treated with antidepressants (<em>p</em> = 0.011). In general linear model analysis treatment with antidepressants, anxiety severity level, their interaction, along with smoking status, drinks intake, and using dietary supplements were shown to significantly explain I-FABP variance (<em>p</em> &lt; 0.001, R<sup>2</sup><sub>adj</sub> = 0.261). Conclusions: Comorbid obesity did not increase intestinal permeability circulating marker, I-FABP, in the population of patients with depressive disorders. Treatment with antidepressants may be connected to higher I-FABP levels. Using dietary supplements, drinks intake, smoking status, or anxiety level may serve as explanatory factors.</div></div>","PeriodicalId":54549,"journal":{"name":"Progress in Neuro-Psychopharmacology & Biological Psychiatry","volume":"136 ","pages":"Article 111170"},"PeriodicalIF":5.3,"publicationDate":"2024-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142407180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetic association and drug target exploration of inflammation-related proteins with risk of major depressive disorder 与重度抑郁症风险有关的炎症相关蛋白的遗传关联和药物靶点探索。
IF 5.3 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-10-09 DOI: 10.1016/j.pnpbp.2024.111165
Wenxi Sun , Hongbao Cao , Dongming Liu , Ancha Baranova , Fuquan Zhang , Xiaobin Zhang

Background

In numerous observational studies, circulating inflammation-related proteins have been linked with major depressive disorder (MDD), yet the precise causal direction of this relationship remains unclear. This study aims to investigate the potential causal link between inflammation-related proteins and the risk of developing MDD.

Methods

We utilized summary data from a genome-wide association study (GWAS) of 91 circulating inflammation-associated proteins in 14,824 individuals of European descent. Additionally, we incorporated findings from a substantial GWAS on MDD, which included 294,322 cases and 741,438 controls. Our analysis employed a two-sample bidirectional Mendelian randomization (MR) approach, with inverse variance weighting (IVW) as the primary method. We augmented this with two supplementary techniques (MR-Egger and weighted median approaches) to detect and address potential pleiotropy. Furthermore, to identify and evaluate possible drug targets, we conducted a thorough search within the Drug-Gene Interaction Database (DGIdb).

Results

Analysis using MR unveiled significant and causative associations between genetically determined CASP-8 (odds ratio (OR): 0.97), CD40 (OR: 0.96), IL-18 (OR: 0.98), SLAMF1 (OR: 0.97), and uPA (OR: 0.98) with MDD. Conversely, reverse MR analysis indicated causal associations between MDD and CCL19 (OR: 1.15), HGF (OR: 1.15), IL-8 (OR: 1.10), IL-18 (OR: 1.11), IL20RA (OR: 1.12), TGFA (OR: 1.12) and TNFSF14 (OR: 1.16). Notably, a significant bidirectional causal link was observed between IL-18 and MDD. Gene-drug analysis identified CD40, HGF, IL-8, IL-18, SLAMF1, and TGFA as potential therapeutic targets.

Conclusions

We've pinpointed causal links between inflammation-related proteins and MDD, offering compelling and innovative evidence to enhance our understanding of the inflammatory mechanisms involved in MDD and to investigate potential targets for anti-MDD medications.
背景:在许多观察性研究中,循环炎症相关蛋白与重度抑郁症(MDD)有关,但这种关系的确切因果方向仍不清楚。本研究旨在调查炎症相关蛋白与罹患重度抑郁症风险之间的潜在因果关系:我们利用全基因组关联研究(GWAS)的汇总数据,对 14,824 名欧洲后裔的 91 种循环炎症相关蛋白进行了研究。此外,我们还纳入了一项关于 MDD 的大型全基因组关联研究的结果,其中包括 294,322 例病例和 741,438 例对照。我们的分析采用了双样本双向孟德尔随机化(MR)方法,以反向方差加权(IVW)为主要方法。我们还采用了两种辅助技术(MR-Egger 法和加权中值法)来检测和解决潜在的多效性问题。此外,为了确定和评估可能的药物靶点,我们在药物基因相互作用数据库(DGIdb)中进行了全面搜索:结果:使用MR分析揭示了基因决定的CASP-8(几率比(OR):0.97)、CD40(OR:0.96)、IL-18(OR:0.98)、SLAMF1(OR:0.97)和uPA(OR:0.98)与MDD之间的显著因果关系。相反,反向 MR 分析表明 MDD 与 CCL19(OR:1.15)、HGF(OR:1.15)、IL-8(OR:1.10)、IL-18(OR:1.11)、IL20RA(OR:1.12)、TGFA(OR:1.12)和 TNFSF14(OR:1.16)之间存在因果关系。值得注意的是,IL-18 与 MDD 之间存在明显的双向因果关系。基因药物分析发现,CD40、HGF、IL-8、IL-18、SLAMF1 和 TGFA 是潜在的治疗靶点:我们发现了炎症相关蛋白与 MDD 之间的因果关系,为我们进一步了解 MDD 所涉及的炎症机制和研究抗 MDD 药物的潜在靶点提供了令人信服的创新证据。
{"title":"Genetic association and drug target exploration of inflammation-related proteins with risk of major depressive disorder","authors":"Wenxi Sun ,&nbsp;Hongbao Cao ,&nbsp;Dongming Liu ,&nbsp;Ancha Baranova ,&nbsp;Fuquan Zhang ,&nbsp;Xiaobin Zhang","doi":"10.1016/j.pnpbp.2024.111165","DOIUrl":"10.1016/j.pnpbp.2024.111165","url":null,"abstract":"<div><h3>Background</h3><div>In numerous observational studies, circulating inflammation-related proteins have been linked with major depressive disorder (MDD), yet the precise causal direction of this relationship remains unclear. This study aims to investigate the potential causal link between inflammation-related proteins and the risk of developing MDD.</div></div><div><h3>Methods</h3><div>We utilized summary data from a genome-wide association study (GWAS) of 91 circulating inflammation-associated proteins in 14,824 individuals of European descent. Additionally, we incorporated findings from a substantial GWAS on MDD, which included 294,322 cases and 741,438 controls. Our analysis employed a two-sample bidirectional Mendelian randomization (MR) approach, with inverse variance weighting (IVW) as the primary method. We augmented this with two supplementary techniques (MR-Egger and weighted median approaches) to detect and address potential pleiotropy. Furthermore, to identify and evaluate possible drug targets, we conducted a thorough search within the Drug-Gene Interaction Database (DGIdb).</div></div><div><h3>Results</h3><div>Analysis using MR unveiled significant and causative associations between genetically determined CASP-8 (odds ratio (OR): 0.97), CD40 (OR: 0.96), IL-18 (OR: 0.98), SLAMF1 (OR: 0.97), and uPA (OR: 0.98) with MDD. Conversely, reverse MR analysis indicated causal associations between MDD and CCL19 (OR: 1.15), HGF (OR: 1.15), IL-8 (OR: 1.10), IL-18 (OR: 1.11), IL20RA (OR: 1.12), TGFA (OR: 1.12) and TNFSF14 (OR: 1.16). Notably, a significant bidirectional causal link was observed between IL-18 and MDD. Gene-drug analysis identified CD40, HGF, IL-8, IL-18, SLAMF1, and TGFA as potential therapeutic targets.</div></div><div><h3>Conclusions</h3><div>We've pinpointed causal links between inflammation-related proteins and MDD, offering compelling and innovative evidence to enhance our understanding of the inflammatory mechanisms involved in MDD and to investigate potential targets for anti-MDD medications.</div></div>","PeriodicalId":54549,"journal":{"name":"Progress in Neuro-Psychopharmacology & Biological Psychiatry","volume":"136 ","pages":"Article 111165"},"PeriodicalIF":5.3,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142395291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Melanin-concentrating hormone promotes feeding through the lateral septum 黑色素浓缩激素促进通过侧隔膜进食。
IF 5.3 2区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-10-09 DOI: 10.1016/j.pnpbp.2024.111163
Mikayla A. Payant, Anjali Shankhatheertha, Melissa J. Chee
Feeding is necessary for survival but can be hindered by anxiety or fear, thus neural systems that can regulate anxiety states are key to elucidating the expression of food-related behaviors. Melanin-concentrating hormone (MCH) is a neuropeptide produced in the lateral hypothalamus and zona incerta that promotes feeding and anxiogenesis. The orexigenic actions of MCH that prolong ongoing homeostatic or hedonic feeding are context-dependent and more prominent in male than female rodents, but it is not clear where MCH acts to initiate feeding. The lateral septum (LS) promotes feeding and suppresses anxiogenesis when inhibited, and it comprises the densest projections from MCH neurons. However, it is not known whether the LS is a major contributor to MCH-mediated feeding. As MCH inhibits LS cells by MCH receptor (MCHR1) activation, MCH may promote feeding via the LS. We bilaterally infused MCH into the LS and found that MCH elicited a rapid and long-lasting increase in the consumption of standard chow and a palatable, high sugar diet in male and female mice; these MCH effects were blocked by the co-administration of a MCHR1 antagonist TC- MCH 7c. Interestingly, the orexigenic effect of MCH was abolished in a novel, anxiogenic environment even when presented with a food reward, but MCH did not induce anxiety-like behaviors. These findings indicated the LS as a novel region underlying orexigenic MCH actions, which stimulated and enhanced feeding in both sexes in a context -dependent manner that was most prominent in the homecage.
进食是生存的必要条件,但焦虑或恐惧会阻碍进食,因此能够调节焦虑状态的神经系统是阐明食物相关行为表现的关键。黑色素浓缩激素(MCH)是一种产生于下丘脑外侧和内侧的神经肽,可促进摄食和焦虑的产生。MCH 的促食欲作用可延长正在进行的平衡性或享乐性摄食,这种作用与环境有关,在雄性啮齿动物中比在雌性啮齿动物中更为突出,但目前尚不清楚 MCH 在哪里起作用启动摄食。外侧隔(LS)在受到抑制时会促进摄食并抑制焦虑发生,它包括来自 MCH 神经元的最密集的投射。然而,LS 是否是 MCH 介导的摄食的主要贡献者尚不清楚。由于 MCH 通过激活 MCH 受体(MCHR1)抑制 LS 细胞,因此 MCH 可能通过 LS 促进进食。我们将 MCH 双侧注入 LS,发现 MCH 能快速、持久地增加雄性和雌性小鼠对标准饲料和适口高糖食物的摄入量;同时给予 MCHR1 拮抗剂 TC- MCH 7c 能阻断 MCH 的这些作用。有趣的是,在新的焦虑环境中,即使提供食物奖励,MCH 的促矿物质效应也会消失,但 MCH 不会诱发焦虑样行为。这些研究结果表明,LS是MCH诱食性作用的一个新的基础区域,它以一种依赖于环境的方式刺激和增强了雌雄动物的摄食,这种作用在同笼中最为突出。
{"title":"Melanin-concentrating hormone promotes feeding through the lateral septum","authors":"Mikayla A. Payant,&nbsp;Anjali Shankhatheertha,&nbsp;Melissa J. Chee","doi":"10.1016/j.pnpbp.2024.111163","DOIUrl":"10.1016/j.pnpbp.2024.111163","url":null,"abstract":"<div><div>Feeding is necessary for survival but can be hindered by anxiety or fear, thus neural systems that can regulate anxiety states are key to elucidating the expression of food-related behaviors. Melanin-concentrating hormone (MCH) is a neuropeptide produced in the lateral hypothalamus and zona incerta that promotes feeding and anxiogenesis. The orexigenic actions of MCH that prolong ongoing homeostatic or hedonic feeding are context-dependent and more prominent in male than female rodents, but it is not clear where MCH acts to initiate feeding. The lateral septum (LS) promotes feeding and suppresses anxiogenesis when inhibited, and it comprises the densest projections from MCH neurons. However, it is not known whether the LS is a major contributor to MCH-mediated feeding. As MCH inhibits LS cells by MCH receptor (MCHR1) activation, MCH may promote feeding via the LS. We bilaterally infused MCH into the LS and found that MCH elicited a rapid and long-lasting increase in the consumption of standard chow and a palatable, high sugar diet in male and female mice; these MCH effects were blocked by the co-administration of a MCHR1 antagonist TC- MCH 7c. Interestingly, the orexigenic effect of MCH was abolished in a novel, anxiogenic environment even when presented with a food reward, but MCH did not induce anxiety-like behaviors. These findings indicated the LS as a novel region underlying orexigenic MCH actions, which stimulated and enhanced feeding in both sexes in a context -dependent manner that was most prominent in the homecage.</div></div>","PeriodicalId":54549,"journal":{"name":"Progress in Neuro-Psychopharmacology & Biological Psychiatry","volume":"136 ","pages":"Article 111163"},"PeriodicalIF":5.3,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142402002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Progress in Neuro-Psychopharmacology & Biological Psychiatry
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1